Tempted by Low Rates, Pfizer Returns To Term Market After a 10-Year Hiatus

Attractive interest rates lured Pfizer Inc. back to the term debt market with a $250 million offering after a 10-year absence.

Subscribe Now

Access to authoritative analysis and perspective and our data-driven report series.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.